2535. Levofloxacin Prophylaxis in Children with Prolonged Chemotherapy Related Neutropenia: Should We Do It?
Session: Symposium: Old Foes and Emerging Threats: Multidrug-Resistant Bacterial Infections in Children
Saturday, October 6, 2018: 2:00 PM
Room: W 2006-2008
Brian T. Fisher, DO, MSCE, MPH, Department of Pediatrics, Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, PA

Dr. Brian Fisher is an Associate Professor of Pediatrics and Epidemiology in the Division of Infectious Diseases at the Children’s Hospital of Philadelphia (CHOP) and is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine at the University of Pennsylvania. He is a core faculty member of the Pediatric Infectious Diseases Epidemiology and Antimicrobial Stewardship (IDEAS) Research Group at the Center for Pediatric Clinical Effectiveness at CHOP. Dr. Fisher's research focuses on infections in children with immunocompromising conditions. He is particularly interested in prevention and management of infections in children with cancer and recipients of hematopoietic cell transplantation. He serves as the Chair of the Infectious Disease Sub-Committee within the Children’s Oncology Group and the Co-Director of the International Pediatric Fungal Network.


B. T. Fisher, Pfizer: Investigator , Research grant . Merck: Grant Investigator , Research grant and Research support .

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.